Skip to main content

Advertisement

Log in

Remodeling and Repair in Rhinosinusitis

  • Rhinosinusitis (J Mullol, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Remodeling refers to the development of specific but potentially irreversible structural changes in tissue. Caucasian eosinophilic chronic rhinosinusitis (CRS) with polyps associated or not with cystic fibrosis was discriminated by edema from CRS without nasal polyps, characterized by extensive fibrotic fields. However, changes in epithelial and extracellular matrix structures are common findings in all types of chronic inflammatory diseases of upper airways, but rarely specific and highly variable in extend. Recent studies have shown that remodeling in CRS appears to occur in parallel, rather than purely subsequent to inflammation. Furthermore, some preferential remodeling associations can be recognized. Tremendous efforts have been put in research on coagulation factors, cytokines, growth factors, and proteases supporting all phases of upper airway remodeling. The current exploration of other CRS sub-groups and of the particular link with concomitant asthma aims to optimize the classification of CRS and its staging modes and to develop novel therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

BM:

Basement membrane

CF-NP:

Cystic fibrosis nasal polyps

CRS:

Chronic rhinosinusitis

CRSsNP:

Chronic rhinosinusitis without nasal polyps

CRSwNP:

Chronic rhinosinusitis with nasal polyps

CT scan:

Computed tomography scanning

ECM:

Extracellular matrix

ECP:

Eosinophil cationic protein

FXIII-A:

Coagulation factor XIII

FGF:

Fibroblast growth factor

fMLP:

Formyl-methionyl-leucyl-phenylalanine

FOXP3:

Forkhead box P3

FPR:

N-formyl peptide receptor

IL:

Interleukin

MMP:

Matrix metalloproteinases

PAI-1:

Plasminogen activator inhibitor-1

PAR-1:

Protease activator receptor-1

PDGF:

Platelet-derived growth factor

TAT:

Thrombin-antithrombin complex

TIMP:

Tissue inhibitor of metalloproteinases

TGF-beta1:

Transforming growth factor beta 1

tPA:

Tissue plasminogen activator

uPAR:

Urokinase-type plasminogen activator receptor

VEGF:

Vascular endothelial growth factor

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Redington AE. Fibrosis and airway remodeling. Clin Exp Allergy. 2000;30 suppl 1:42–5.

    Article  PubMed  Google Scholar 

  2. Watelet JB, Van Zele T, Gjormarkaj M, Canonica GW, Dahlen SE, Fokkens W, et al. Tissue remodelling in upper airways: where is the link with lower airway remodeling? Allergy. 2006;61(11):1249–58.

    Article  CAS  PubMed  Google Scholar 

  3. Pawankar R, Nonaka M. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep. 2007;7:202–8. This article reviews systematically the different remodeling profiles in the two main subgroups of CRS: CRSsNP and CRSwNP.

    Article  CAS  PubMed  Google Scholar 

  4. Pezato R, Balsalobre L, Lima M, Bezerra TF, Voegels RL, Gregório LC, et al. Convergence of two major pathophysiologic mechanisms in nasal polyposis: immune response to Staphylococcus aureus and airway remodeling. J Otolaryngol Head Neck Surg. 2013;42:27.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Hsu J, Peters AT. Pathophysiology of chronic rhinosinusitis with nasal polyp. Am J Rhinol Allergy. 2011;25(5):285–90.

    Article  PubMed  Google Scholar 

  6. Eloy P, Poirrier AL, De Dorlodot C, Van Zele T, Watelet JB, Bertrand B. Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management. Curr Allergy Asthma Rep. 2011;11(2):146–62.

    Article  CAS  PubMed  Google Scholar 

  7. Van Bruaene N, Bachert C. Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2011;11(1):8–11. This article highlights the role of TGF-beta in upper airway remodeling.

    Article  PubMed  Google Scholar 

  8. Thiele A, Holzhausen HJ, Riederer A, Knipping S. Mucosal remodeling in chronic rhinosinusitis without nasal polyposis—an ultrastructural evaluation. Laryngorhinootologie. 2010;89(6):352–7.

    Article  CAS  PubMed  Google Scholar 

  9. Bousquet J, Jacquot W, Vignola AM, Bachert C, Van Cauwenberge P. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol. 2004;113:43–9. This paper was one of the first reviews on the particular role of upper airway remodeling in the maintenance of upper airway inflammation.

    Article  CAS  PubMed  Google Scholar 

  10. Hsu J, Avila PC, Kern RC, Hayes MG, Schleimer RP, Pinto JM. Genetics of chronic rhinosinusitis: state of the field and directions forward. J Allergy Clin Immunol. 2013;131(4):977–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280–9.

    Article  PubMed  Google Scholar 

  12. Nguyen KH, Suzuki H, Wakasugi T, Hohchi N, Hashida K, Ohbuchi T. Different expressions of erbB1/2 and tight junction proteins in hypertrophic inferior turbinates and nasal polyps. Eur Arch Otorhinolaryngol. 2013;270(3):945–51.

    Article  PubMed  Google Scholar 

  13. De Coster L, Eloy P, Ferdinande L, Taeldeman J, Cuvelier C, Watelet JB. Different types of tissue composition in inflammatory or reparative in chronic upper airway disorders. Rhinology. 2012;50(4):393–401.

    PubMed  Google Scholar 

  14. Meng J, Zhou P, Liu Y, Liu F, Yi X, Liu S, et al. The development of nasal polyp disease involves early nasal mucosal inflammation and remodeling. PLoS One. 2013;8(12):e82373. This publication explores the chronological order and relationship between inflammation and remodeling in polyp development.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Cho SH, Shin KS, Lee YS, Jeong JH, Lee SH, Tae K, et al. Impact of chronic rhinosinusitis and endoscopic sinus surgery on bone remodeling of the paranasal sinuses. Am J Rhinol. 2008;22(5):537–41.

    Article  PubMed  Google Scholar 

  16. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–904.

    Article  CAS  PubMed  Google Scholar 

  17. Law RH, Abu-Ssaydeh D, Whisstock JC. New insights into the structure and function of the plasminogen/plasmin system. Curr Opin Struct Biol. 2013;23(6):836–41.

    Article  CAS  PubMed  Google Scholar 

  18. Takabayashi T, Kato A, Peters AT, Hulse KE, Suh LA, Carter R, et al. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression. Am J Respir Crit Care Med. 2013;187(1):49–57. The authors hypothesized that formation of a fibrin mesh retains plasma proteins in CRSwNP.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Sejima T, Holtappels G, Bachert C. The expression of fibrinolytic components in chronic paranasal sinus disease. Am J Rhinol Allergy. 2011;25(1):1–6.

    Article  PubMed  Google Scholar 

  20. Shimizu S, Gabazza EC, Ogawa T, Tojima I, Hoshi E, Kouzaki H, et al. Role of thrombin in chronic rhinosinusitis-associated tissue remodeling. Am J Rhinol Allergy. 2011;25(1):7–11.

    Article  PubMed  Google Scholar 

  21. Lord ST. Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol. 2011;31(3):494–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Hoppe B. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation. Thromb Haemost. 2014;112:649–58.

    Article  PubMed  Google Scholar 

  23. Inbal A, Lubetsky A, Krapp T, Castel D, Shaish A, Dickneitte G, et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost. 2005;94(2):432–7.

    CAS  PubMed  Google Scholar 

  24. Dardik R, Krapp T, Rosenthal E, Loscalzo J, Inbal A. Effect of FXIII on monocyte and fibroblast function. Cell Physiol Biochem. 2007;19(1–4):113–20.

    Article  CAS  PubMed  Google Scholar 

  25. Dardik R, Loscalzo J, Inbal A. Factor XIII (FXIII) and angiogenesis. J Thromb Haemost. 2006;4(1):19–25.

    Article  CAS  PubMed  Google Scholar 

  26. Takabayashi T, Kato A, Peters AT, Hulse KE, Suh LA, Carter R, et al. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2013;132(3):584–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Kou W, Guo-Hua H, Yao H-B, Wang X, Shen Y, Kang H-Y, et al. Regulation of transforming growth factor-1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis. ORL. 2012;74:172–8.

    Article  CAS  PubMed  Google Scholar 

  28. Li YC, An YS, Wang T, Zang HR. Analysis of transforming growth factor β signaling in chronic rhinosinusitis. Chin Med J (Engl). 2013;126(17):3340–3.

    CAS  Google Scholar 

  29. Daines SM, Wang Y, Orlandi RR. Periostin and osteopontin are overexpressed in chronically inflamed sinuses. Int Forum Allergy Rhinol. 2011;1(2):101–5.

    Article  PubMed  Google Scholar 

  30. Kostamo K, Toskala E, Tervahartiala T, Sorsa T. Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2008;8(1):21–7.

    Article  CAS  PubMed  Google Scholar 

  31. de Borja Callejas F, Picado C, Martínez-Antón A, Alobid I, Pujols L, Valero A, et al. Differential expression of remodeling markers by tissue structure in nasal polyposis. Am J Rhinol Allergy. 2013;27(3):e69–74. This study establishes a qualitative/semiquantitative method of analysis on the expression of these remodeling markers in different tissue structures and eosinophils in both NPs and nasal mucosa (NM).

    Article  PubMed  Google Scholar 

  32. Detwiller KY, Smith TL, Mace JC, Trune DR, Sautter NB. Steroid-independent upregulation of MMP9 in chronic rhinosinusitis patients with radiographic evidence of osteitis. Int Forum Allergy Rhinol. 2013;3(5):364–8.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Malinsky RR, Valera FC, Cavallari FE, Küpper DS, Milaneze C, Silva JS, et al. Matrix metalloproteinases and their impact on sinusal extension in chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol. 2013;270(4):1345–8.

    Article  PubMed  Google Scholar 

  34. Wang LF, Chien CY, Chiang FY, Chai CY, Tai CF. Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy. 2012;26(1):e1–4.

    Article  PubMed  Google Scholar 

  35. Sautter NB, Delaney KL, Trune DR. Altered expression of tissue remodeling genes in a mouse model of acute allergic rhinitis. Int Forum Allergy Rhinol. 2011;1(4):262–7.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Wang JH, Kwon HJ, Jang YJ. Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps. Am J Rhinol Allergy. 2010;24(6):422–7.

    Article  PubMed  Google Scholar 

  37. Rom D, Snidvongs K, Sacks PL, Dalgorf D, Pratt E, Earls P, et al. The impact of culturable bacterial community on histopathology in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(1):29–33.

    Article  PubMed  Google Scholar 

  38. Wang LF, Chien CY, Chiang FY, Chai CY, Tai CF. Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis. Kaohsiung J Med Sci. 2013;29(1):26–31.

    Article  PubMed  Google Scholar 

  39. Loxham M, Davies DE, Blume C. Epithelial function and dysfunction in asthma. Clin Exp Allergy. 2014;44(11):1299–313.

    Article  CAS  PubMed  Google Scholar 

  40. Yan Y, Gordon WM, Wang DY. Nasal epithelial repair and remodeling in physical injury, infection, and inflammatory diseases. Curr Opin Otolaryngol Head Neck Surg. 2013;21:263–70.

    Article  PubMed  Google Scholar 

  41. Saitoh T, Kusunoki T, Yao T, Kawano K, Kojima Y, Miyahara K, et al. Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis. Rhinology. 2009;47(3):275–9.

    PubMed  Google Scholar 

  42. Saitoh T, Kusunoki T, Yao T, Kawano K, Kojima Y, Miyahara K, et al. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma. Int Arch Allergy Immunol. 2010;151(1):8–16.

    Article  CAS  PubMed  Google Scholar 

  43. Shikani AH, Sidhaye VK, Basaraba RJ, Shikani HJ, Alqudah MA, Kirk N, et al. Mucosal expression of aquaporin 5 and epithelial barrier proteins in chronic rhinosinusitis with and without nasal polyps. Am J Otolaryngol. 2014;35(3):377–83.

    Article  PubMed  Google Scholar 

  44. Prevete N, Salzano FA, Rossi FW, Rivellese F, Dellepiane M, Guastini L, et al. Role(s) of formyl-peptide receptors expressed in nasal epithelial cells. J Biol Regul Homeost Agents. 2011;25(4):553–64.

    CAS  PubMed  Google Scholar 

  45. Kouzaki H, Seno S, Fukui J, Owaki S, Shimizu T. Role of platelet-derived growth factor in airway remodeling in rhinosinusitis. Am J Rhinol Allergy. 2009;23(3):273–80.

    Article  PubMed  Google Scholar 

  46. Sacre-Hazouri JA. Chronic rhinosinusitis in children. Rev Alerg Mex. 2012;59(1):16–24.

    PubMed  Google Scholar 

  47. Bernheim N, Doyen A, Eloy P, Halewyck S, Hellings PW, Mardyla N, et al. Biological conditions affecting chronic inflammation in upper airways in children. B-ENT. 2012;8 Suppl 19:41–71.

    PubMed  Google Scholar 

  48. Zhang N, Liu S, Lin P, Li X, van Bruaene N, Zhang J, et al. Remodeling and inflammation in Chinese versus white patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2010;125(2):507. author reply 507–8.

    Article  PubMed  Google Scholar 

  49. Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009;124(3):478–84.

    Article  CAS  PubMed  Google Scholar 

  50. Li X, Meng J, Qiao X, Liu Y, Liu F, Zhang N, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol. 2010;125(5):1061–8.

    Article  CAS  PubMed  Google Scholar 

  51. Shi LL, Xiong P, Zhang L, Cao PP, Liao B, Lu X, et al. Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns. Allergy. 2013;68(1):101–9.

    Article  CAS  PubMed  Google Scholar 

  52. Bassiouni A, Naidoo Y, Wormald PJ. Does mucosal remodeling in chronic rhinosinusitis result in irreversible mucosal disease? Laryngoscope. 2012;122(1):225–9.

    Article  PubMed  Google Scholar 

  53. Rehl RM, Balla AA, Cabay RJ, Hearp ML, Pytynia KB, Joe SA. Mucosal remodeling in chronic rhinosinusitis. Am J Rhinol. 2007;21(6):651–7.

    Article  PubMed  Google Scholar 

  54. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–76. This double-blind, placebo-controlled, multicenter trial evaluates the effects of oral glucocorticoids and doxycycline on symptoms and objective clinical and biological parameters in patients with chronic rhinosinusitis and nasal polyps.

    Article  PubMed  Google Scholar 

  55. Callejas FB, Martínez-Antón A, Picado C, Alobid I, Pujols L, Valero A, et al. Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps. Laryngoscope. 2015. doi:10.1002/lary.25147.

    Google Scholar 

  56. Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131(1):110–6.

    Article  CAS  PubMed  Google Scholar 

  57. Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989–95.

    Article  CAS  PubMed  Google Scholar 

  58. Birk R, Grossbaier J, Aderhold C, Stern-Sträter J, Hörmann K, Sauter A, et al. Anti-inflammatory effects of polihexanide and polyethylene glycol in an in vitro study in chronic rhinosinusitis. In Vivo. 2014;28(4):489–94.

    CAS  PubMed  Google Scholar 

  59. Sommer JU, Schultz JD, Grossbaier J, Stern-Straeter J, Hörmann K, Sauter A. In vitro effects of doxycycline on inflammatory cytokines and gelatinases in chronic rhinosinusitis. In Vivo. 2012;26(3):369–74.

    CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Jean-Baptiste Watelet, Jean-Michel Dogne, and François Mullier declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Baptiste Watelet.

Additional information

This article is part of the Topical Collection on Rhinosinusitis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watelet, JB., Dogne, JM. & Mullier, F. Remodeling and Repair in Rhinosinusitis. Curr Allergy Asthma Rep 15, 34 (2015). https://doi.org/10.1007/s11882-015-0531-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-015-0531-3

Keywords

Navigation